These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30625040)

  • 21. The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer.
    Mema E; Schnabel F; Chun J; Kaplowitz E; Price A; Goodgal J; Moy L
    Eur J Radiol; 2020 Mar; 124():108813. PubMed ID: 31927471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
    Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
    Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of background parenchymal enhancement on breast MRI: a systematic review.
    Bignotti B; Signori A; Valdora F; Rossi F; Calabrese M; Durando M; Mariscotto G; Tagliafico A
    Br J Radiol; 2017 Feb; 90(1070):20160542. PubMed ID: 27925480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic density, MRI background parenchymal enhancement and breast cancer risk.
    Pike MC; Pearce CL
    Ann Oncol; 2013 Nov; 24 Suppl 8(Suppl 8):viii37-viii41. PubMed ID: 24131968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
    King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
    Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.
    Lim Y; Ko ES; Han BK; Ko EY; Choi JS; Lee JE; Lee SK
    Breast Cancer Res Treat; 2017 Jun; 163(3):573-586. PubMed ID: 28349273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
    Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
    J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
    Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
    Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status.
    Goodburn R; Kousi E; Sanders C; Macdonald A; Scurr E; Bunce C; Khabra K; Reddy M; Wilkinson L; O'Flynn E; Allen S; Schmidt MA
    Eur Radiol; 2023 Sep; 33(9):6204-6212. PubMed ID: 37017702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics.
    Kim MY; Choi N; Yang JH; Yoo YB; Park KS
    Clin Radiol; 2015 Jul; 70(7):706-10. PubMed ID: 25824280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk.
    Niell BL; Abdalah M; Stringfield O; Raghunand N; Ataya D; Gillies R; Balagurunathan Y
    AJR Am J Roentgenol; 2021 Jul; 217(1):64-75. PubMed ID: 32876474
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
    Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
    Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.
    Engmann NJ; Golmakani MK; Miglioretti DL; Sprague BL; Kerlikowske K;
    JAMA Oncol; 2017 Sep; 3(9):1228-1236. PubMed ID: 28152151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing Quantitative Parenchymal Features at Baseline Dynamic Contrast-enhanced MRI and Cancer Occurrence in Women with Extremely Dense Breasts.
    Wang H; van der Velden BHM; Verburg E; Bakker MF; Pijnappel RM; Veldhuis WB; van Gils CH; Gilhuijs KGA
    Radiology; 2023 Aug; 308(2):e222841. PubMed ID: 37552061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Background Parenchymal Enhancement at Postoperative Surveillance Breast MRI: Association with Future Second Breast Cancer Risk.
    Lee SH; Jang MJ; Yoen H; Lee Y; Kim YS; Park AR; Ha SM; Kim SY; Chang JM; Cho N; Moon WK
    Radiology; 2023 Jan; 306(1):90-99. PubMed ID: 36040335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.
    Hellgren R; Saracco A; Strand F; Eriksson M; Sundbom A; Hall P; Dickman PW
    Acta Radiol; 2020 Dec; 61(12):1600-1607. PubMed ID: 32216451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response.
    Dong JM; Wang HX; Zhong XF; Xu K; Bian J; Feng Y; Chen L; Zhang L; Wang X; Ma DJ; Wang B
    Medicine (Baltimore); 2018 Oct; 97(43):e12965. PubMed ID: 30412117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.